Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.256
https://www.valueinhealthjournal.com/article/S1098-3015(17)30590-9/fulltext
Title :
Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30590-9&doi=10.1016/j.jval.2017.08.256
First page :
A443
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
234